Hiding In Plain Sight: Uncommon Presentations Of Digoxin Ocular Toxicity
, 2014 Visual symptoms of digoxin toxicity include photopsias, frosted vision, chromatopsias, and vision loss, which can occur even at therapeutic levels. Full field electroretinogram (ERG) easily supports the diagnosis and should be used even in atypical ...
Dov B. Sebrow; Jeffrey G. Odel; Lora R. Dagi Glass; Stephen H. Tsang
core
Chorea in digoxin toxicity. [PDF]
Journal of Neurology, Neurosurgery & Psychiatry, 1984 J A Wedzicha, W R Gibb, A J Lees
openaire +1 more source
Cilostazol-Induced Digoxin Toxicity Presenting as Accelerated Idioventricular Rhythm and Recurrent Syncope. [PDF]
JACC Case RepMadanieh S +4 more
europepmc +1 more source
BRASH Syndrome Unmasked: Digoxin Toxicity in the Setting of Cardiogenic Shock and Multiorgan Dysfunction. [PDF]
Case Rep Crit CareBoehm S, Bruni J.
europepmc +1 more source
Digoxin Toxicity at Standard Doses in a Child with Subclinical Elevation of Thyrotrophin: A Case Report. [PDF]
Drug Healthc Patient SafKhorgami M, Dalili M, Karimian B.
europepmc +1 more source
Efficiency of individual dosage of digoxin with calculated concentration
, 2014 Li Zhao,1,* Peng Yang,2,* Pengmei Li,1 Xiaoxing Wang,1 Wangjun Qin,1 Xianglin Zhang1 1Department of Pharmacy, 2Department of Cardiology, China-Japan Friendship Hospital, Beijing, People’s Republic of China *These authors contributed equally to ...
Zhao L +5 more
core
The use of colour vision measurement in the diagnosis of digoxin toxicity.
, 1980 Colour vision has been measured, using the Farnsworth-Munsell 100-Hue test, in control subjects and in patients taking digoxin. In 10 patients with digitalis toxicity, of whom only two described symptomatic abnormalities, colour vision was impaired ...
Ford, AR, Aronson, JK, Aronson, Jeffrey
core
Digoxin Toxicity in a Patient with Pacemaker: A Case Report. [PDF]
Cureus, 2019 Bridwell RE, Baker KA, Hoyte CO, Ng PC.
europepmc +1 more source
Digoxin Toxicity in Renal Failure: Resolution With Plasma Exchange After Fab Therapy Failure. [PDF]
CureusWilliams JM, Reddy P.
europepmc +1 more source
Phase II trial of second-line erlotinib and digoxin for nonsmall cell lung cancer (NSCLC)
, 2011 Fadi Kayali, Muhamad A Janjua, Damian A Laber, Donald Miller, Goetz H KloeckerUniversity of Louisville, James Graham Brown Cancer Center, Louisville, KY, USABackground: In vitro digoxin sensitizes cancer cells to the induction of apoptosis by ...
Muhamad A Janjua +4 more
core